Apellis Pharmaceuticals, Inc. (APLS) vs Blueprint Medicines Corporation (BPMC)
Detailed comparison between Apellis Pharmaceuticals, Inc., Blueprint Medicines Corporation.Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)Blueprint Medicines Corporation (BPMC)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
Blueprint Medicines Corporation
BPMC
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | Blueprint Medicines Corporation (BPMC) |
|---|---|---|
| Current Price | $29.93 | $110.05 |
| Change | 0.20 (0.69%) | 6.10 (5.87%) |
| Market Cap | $3.72B | $6.99B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -35.64 | -117.07 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $71.90 | $121.90 |
| 52-Week Low | $24.34 | $72.24 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.03 | $-2.09 |
Your store is blocked
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | -9.86% | 0.00% | -54.26% | -30.45% | 113.36% | 113.36% |
| BPMC | 22.09% | 0.00% | 32.56% | 38.01% | 483.20% | 483.20% |